Twin-to-twin transfusion syndrome: an antiangiogenic state?

Objective An imbalanced chronic blood flow between the donor and recipient twin through placental vascular anastomoses is the accepted pathophysiology of twin-to-twin transfusion syndrome (TTTS). Vascular endothelial growth factor receptor-1 (VEGFR-1) mRNA is overexpressed only in the syncytiotropho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2008-04, Vol.198 (4), p.382.e1-382.e8
Hauptverfasser: Kusanovic, Juan Pedro, MD, Romero, Roberto, MD, Espinoza, Jimmy, MD, Nien, Jyh Kae, MD, Kim, Chong Jai, MD, Mittal, Pooja, MD, Edwin, Sam, PhD, Erez, Offer, MD, Gotsch, Francesca, MD, Mazaki-Tovi, Shali, MD, Than, Nandor G., MD, PhD, Soto, Eleazar, MD, Camacho, Natalia, MD, Gomez, Ricardo, MD, Quintero, Ruben, MD, Hassan, Sonia S., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 382.e8
container_issue 4
container_start_page 382.e1
container_title American journal of obstetrics and gynecology
container_volume 198
creator Kusanovic, Juan Pedro, MD
Romero, Roberto, MD
Espinoza, Jimmy, MD
Nien, Jyh Kae, MD
Kim, Chong Jai, MD
Mittal, Pooja, MD
Edwin, Sam, PhD
Erez, Offer, MD
Gotsch, Francesca, MD
Mazaki-Tovi, Shali, MD
Than, Nandor G., MD, PhD
Soto, Eleazar, MD
Camacho, Natalia, MD
Gomez, Ricardo, MD
Quintero, Ruben, MD
Hassan, Sonia S., MD
description Objective An imbalanced chronic blood flow between the donor and recipient twin through placental vascular anastomoses is the accepted pathophysiology of twin-to-twin transfusion syndrome (TTTS). Vascular endothelial growth factor receptor-1 (VEGFR-1) mRNA is overexpressed only in the syncytiotrophoblast of the donor twin in some cases of TTTS. This study was conducted to determine maternal plasma concentrations of placental growth factor (PlGF), soluble VEGFR-1, and soluble endoglin (s-Eng) in monochorionic-diamniotic pregnancies with and without TTTS. Study Design This case-control study included monochorionic-diamniotic pregnancies between 16-26 weeks with and without TTTS. Maternal plasma concentrations of PlGF, sVEGFR-1, and s-Eng were determined with ELISA. A P value < .05 was considered statistically significant. Results Patients with TTTS had higher median plasma concentrations of s-Eng (14.8 ng/mL vs 7.8 ng/mL; P < .001) and sVEGFR-1 (6383.1 pg/mL vs 3220.1 pg/mL; P < .001]; and lower median plasma concentrations of PlGF (115.5 pg/mL vs 359.3 pg/mL; P = .002) than those without TTTS. Conclusion We propose that an antiangiogenic state may be present in some cases of TTTS.
doi_str_mv 10.1016/j.ajog.2008.02.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70482221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000293780800152X</els_id><sourcerecordid>70482221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-cc393165260a9397b1dbe237dde3996add56ffc66b734b7edd63bc4f46c5fe763</originalsourceid><addsrcrecordid>eNp9kVGL1DAQx4N4eOvpF_BB9kXf2pskbdqoKHLoKRz44Am-hTSZLqnd5EzSk_32puyi4IMQGDL8_sPwG0KeUagpUHE51XoKu5oB9DWwurQekA0F2VWiF_1DsgEAVkne9efkcUrT-mWSPSLntOeyBc425PXtL-erHKpc6jZH7dO4JBf8Nh28jWGPr7bal5ed9jsXduid2aasM757Qs5GPSd8eqoX5NvHD7dXn6qbL9efr97fVKbpea6M4ZJT0TIBWnLZDdQOyHhnLXIphba2FeNohBg63gwdWiv4YJqxEaYdsRP8grw8zr2L4eeCKau9SwbnWXsMS1IdND1jjBaQHUETQ0oRR3UX3V7Hg6KgVmVqUqsytSpTwFRpldDz0_Rl2KP9Gzk5KsCLE6CT0fNYHBmX_nAMWCOoaAr35shhcXHvMKpkHHqD1kU0Wdng_r_H23_iZnZFtp5_4AHTFJboi2VFVSoB9XW95npb6AFoy77z35tvns0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70482221</pqid></control><display><type>article</type><title>Twin-to-twin transfusion syndrome: an antiangiogenic state?</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kusanovic, Juan Pedro, MD ; Romero, Roberto, MD ; Espinoza, Jimmy, MD ; Nien, Jyh Kae, MD ; Kim, Chong Jai, MD ; Mittal, Pooja, MD ; Edwin, Sam, PhD ; Erez, Offer, MD ; Gotsch, Francesca, MD ; Mazaki-Tovi, Shali, MD ; Than, Nandor G., MD, PhD ; Soto, Eleazar, MD ; Camacho, Natalia, MD ; Gomez, Ricardo, MD ; Quintero, Ruben, MD ; Hassan, Sonia S., MD</creator><creatorcontrib>Kusanovic, Juan Pedro, MD ; Romero, Roberto, MD ; Espinoza, Jimmy, MD ; Nien, Jyh Kae, MD ; Kim, Chong Jai, MD ; Mittal, Pooja, MD ; Edwin, Sam, PhD ; Erez, Offer, MD ; Gotsch, Francesca, MD ; Mazaki-Tovi, Shali, MD ; Than, Nandor G., MD, PhD ; Soto, Eleazar, MD ; Camacho, Natalia, MD ; Gomez, Ricardo, MD ; Quintero, Ruben, MD ; Hassan, Sonia S., MD</creatorcontrib><description>Objective An imbalanced chronic blood flow between the donor and recipient twin through placental vascular anastomoses is the accepted pathophysiology of twin-to-twin transfusion syndrome (TTTS). Vascular endothelial growth factor receptor-1 (VEGFR-1) mRNA is overexpressed only in the syncytiotrophoblast of the donor twin in some cases of TTTS. This study was conducted to determine maternal plasma concentrations of placental growth factor (PlGF), soluble VEGFR-1, and soluble endoglin (s-Eng) in monochorionic-diamniotic pregnancies with and without TTTS. Study Design This case-control study included monochorionic-diamniotic pregnancies between 16-26 weeks with and without TTTS. Maternal plasma concentrations of PlGF, sVEGFR-1, and s-Eng were determined with ELISA. A P value &lt; .05 was considered statistically significant. Results Patients with TTTS had higher median plasma concentrations of s-Eng (14.8 ng/mL vs 7.8 ng/mL; P &lt; .001) and sVEGFR-1 (6383.1 pg/mL vs 3220.1 pg/mL; P &lt; .001]; and lower median plasma concentrations of PlGF (115.5 pg/mL vs 359.3 pg/mL; P = .002) than those without TTTS. Conclusion We propose that an antiangiogenic state may be present in some cases of TTTS.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2008.02.016</identifier><identifier>PMID: 18395032</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Mosby, Inc</publisher><subject>Adult ; angiogenesis ; angiogenic factors ; Antigens, CD - blood ; Biological and medical sciences ; birthweight discordancy ; Case-Control Studies ; Endoglin ; Enzyme-Linked Immunosorbent Assay ; Female ; Fetofetal Transfusion - blood ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; monochorionic ; Neovascularization, Physiologic ; Obstetrics and Gynecology ; Placenta Growth Factor ; placental growth factor ; PlGF ; Pregnancy ; Pregnancy Proteins - blood ; Receptors, Cell Surface - blood ; sFlt1 ; sVEGFR-1 ; TTTS ; twin pregnancy ; Vascular Endothelial Growth Factor Receptor-1 - blood</subject><ispartof>American journal of obstetrics and gynecology, 2008-04, Vol.198 (4), p.382.e1-382.e8</ispartof><rights>Mosby, Inc.</rights><rights>2008 Mosby, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-cc393165260a9397b1dbe237dde3996add56ffc66b734b7edd63bc4f46c5fe763</citedby><cites>FETCH-LOGICAL-c483t-cc393165260a9397b1dbe237dde3996add56ffc66b734b7edd63bc4f46c5fe763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajog.2008.02.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20246164$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18395032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kusanovic, Juan Pedro, MD</creatorcontrib><creatorcontrib>Romero, Roberto, MD</creatorcontrib><creatorcontrib>Espinoza, Jimmy, MD</creatorcontrib><creatorcontrib>Nien, Jyh Kae, MD</creatorcontrib><creatorcontrib>Kim, Chong Jai, MD</creatorcontrib><creatorcontrib>Mittal, Pooja, MD</creatorcontrib><creatorcontrib>Edwin, Sam, PhD</creatorcontrib><creatorcontrib>Erez, Offer, MD</creatorcontrib><creatorcontrib>Gotsch, Francesca, MD</creatorcontrib><creatorcontrib>Mazaki-Tovi, Shali, MD</creatorcontrib><creatorcontrib>Than, Nandor G., MD, PhD</creatorcontrib><creatorcontrib>Soto, Eleazar, MD</creatorcontrib><creatorcontrib>Camacho, Natalia, MD</creatorcontrib><creatorcontrib>Gomez, Ricardo, MD</creatorcontrib><creatorcontrib>Quintero, Ruben, MD</creatorcontrib><creatorcontrib>Hassan, Sonia S., MD</creatorcontrib><title>Twin-to-twin transfusion syndrome: an antiangiogenic state?</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective An imbalanced chronic blood flow between the donor and recipient twin through placental vascular anastomoses is the accepted pathophysiology of twin-to-twin transfusion syndrome (TTTS). Vascular endothelial growth factor receptor-1 (VEGFR-1) mRNA is overexpressed only in the syncytiotrophoblast of the donor twin in some cases of TTTS. This study was conducted to determine maternal plasma concentrations of placental growth factor (PlGF), soluble VEGFR-1, and soluble endoglin (s-Eng) in monochorionic-diamniotic pregnancies with and without TTTS. Study Design This case-control study included monochorionic-diamniotic pregnancies between 16-26 weeks with and without TTTS. Maternal plasma concentrations of PlGF, sVEGFR-1, and s-Eng were determined with ELISA. A P value &lt; .05 was considered statistically significant. Results Patients with TTTS had higher median plasma concentrations of s-Eng (14.8 ng/mL vs 7.8 ng/mL; P &lt; .001) and sVEGFR-1 (6383.1 pg/mL vs 3220.1 pg/mL; P &lt; .001]; and lower median plasma concentrations of PlGF (115.5 pg/mL vs 359.3 pg/mL; P = .002) than those without TTTS. Conclusion We propose that an antiangiogenic state may be present in some cases of TTTS.</description><subject>Adult</subject><subject>angiogenesis</subject><subject>angiogenic factors</subject><subject>Antigens, CD - blood</subject><subject>Biological and medical sciences</subject><subject>birthweight discordancy</subject><subject>Case-Control Studies</subject><subject>Endoglin</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Fetofetal Transfusion - blood</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>monochorionic</subject><subject>Neovascularization, Physiologic</subject><subject>Obstetrics and Gynecology</subject><subject>Placenta Growth Factor</subject><subject>placental growth factor</subject><subject>PlGF</subject><subject>Pregnancy</subject><subject>Pregnancy Proteins - blood</subject><subject>Receptors, Cell Surface - blood</subject><subject>sFlt1</subject><subject>sVEGFR-1</subject><subject>TTTS</subject><subject>twin pregnancy</subject><subject>Vascular Endothelial Growth Factor Receptor-1 - blood</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVGL1DAQx4N4eOvpF_BB9kXf2pskbdqoKHLoKRz44Am-hTSZLqnd5EzSk_32puyi4IMQGDL8_sPwG0KeUagpUHE51XoKu5oB9DWwurQekA0F2VWiF_1DsgEAVkne9efkcUrT-mWSPSLntOeyBc425PXtL-erHKpc6jZH7dO4JBf8Nh28jWGPr7bal5ed9jsXduid2aasM757Qs5GPSd8eqoX5NvHD7dXn6qbL9efr97fVKbpea6M4ZJT0TIBWnLZDdQOyHhnLXIphba2FeNohBg63gwdWiv4YJqxEaYdsRP8grw8zr2L4eeCKau9SwbnWXsMS1IdND1jjBaQHUETQ0oRR3UX3V7Hg6KgVmVqUqsytSpTwFRpldDz0_Rl2KP9Gzk5KsCLE6CT0fNYHBmX_nAMWCOoaAr35shhcXHvMKpkHHqD1kU0Wdng_r_H23_iZnZFtp5_4AHTFJboi2VFVSoB9XW95npb6AFoy77z35tvns0</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Kusanovic, Juan Pedro, MD</creator><creator>Romero, Roberto, MD</creator><creator>Espinoza, Jimmy, MD</creator><creator>Nien, Jyh Kae, MD</creator><creator>Kim, Chong Jai, MD</creator><creator>Mittal, Pooja, MD</creator><creator>Edwin, Sam, PhD</creator><creator>Erez, Offer, MD</creator><creator>Gotsch, Francesca, MD</creator><creator>Mazaki-Tovi, Shali, MD</creator><creator>Than, Nandor G., MD, PhD</creator><creator>Soto, Eleazar, MD</creator><creator>Camacho, Natalia, MD</creator><creator>Gomez, Ricardo, MD</creator><creator>Quintero, Ruben, MD</creator><creator>Hassan, Sonia S., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Twin-to-twin transfusion syndrome: an antiangiogenic state?</title><author>Kusanovic, Juan Pedro, MD ; Romero, Roberto, MD ; Espinoza, Jimmy, MD ; Nien, Jyh Kae, MD ; Kim, Chong Jai, MD ; Mittal, Pooja, MD ; Edwin, Sam, PhD ; Erez, Offer, MD ; Gotsch, Francesca, MD ; Mazaki-Tovi, Shali, MD ; Than, Nandor G., MD, PhD ; Soto, Eleazar, MD ; Camacho, Natalia, MD ; Gomez, Ricardo, MD ; Quintero, Ruben, MD ; Hassan, Sonia S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-cc393165260a9397b1dbe237dde3996add56ffc66b734b7edd63bc4f46c5fe763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>angiogenesis</topic><topic>angiogenic factors</topic><topic>Antigens, CD - blood</topic><topic>Biological and medical sciences</topic><topic>birthweight discordancy</topic><topic>Case-Control Studies</topic><topic>Endoglin</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Fetofetal Transfusion - blood</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>monochorionic</topic><topic>Neovascularization, Physiologic</topic><topic>Obstetrics and Gynecology</topic><topic>Placenta Growth Factor</topic><topic>placental growth factor</topic><topic>PlGF</topic><topic>Pregnancy</topic><topic>Pregnancy Proteins - blood</topic><topic>Receptors, Cell Surface - blood</topic><topic>sFlt1</topic><topic>sVEGFR-1</topic><topic>TTTS</topic><topic>twin pregnancy</topic><topic>Vascular Endothelial Growth Factor Receptor-1 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kusanovic, Juan Pedro, MD</creatorcontrib><creatorcontrib>Romero, Roberto, MD</creatorcontrib><creatorcontrib>Espinoza, Jimmy, MD</creatorcontrib><creatorcontrib>Nien, Jyh Kae, MD</creatorcontrib><creatorcontrib>Kim, Chong Jai, MD</creatorcontrib><creatorcontrib>Mittal, Pooja, MD</creatorcontrib><creatorcontrib>Edwin, Sam, PhD</creatorcontrib><creatorcontrib>Erez, Offer, MD</creatorcontrib><creatorcontrib>Gotsch, Francesca, MD</creatorcontrib><creatorcontrib>Mazaki-Tovi, Shali, MD</creatorcontrib><creatorcontrib>Than, Nandor G., MD, PhD</creatorcontrib><creatorcontrib>Soto, Eleazar, MD</creatorcontrib><creatorcontrib>Camacho, Natalia, MD</creatorcontrib><creatorcontrib>Gomez, Ricardo, MD</creatorcontrib><creatorcontrib>Quintero, Ruben, MD</creatorcontrib><creatorcontrib>Hassan, Sonia S., MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kusanovic, Juan Pedro, MD</au><au>Romero, Roberto, MD</au><au>Espinoza, Jimmy, MD</au><au>Nien, Jyh Kae, MD</au><au>Kim, Chong Jai, MD</au><au>Mittal, Pooja, MD</au><au>Edwin, Sam, PhD</au><au>Erez, Offer, MD</au><au>Gotsch, Francesca, MD</au><au>Mazaki-Tovi, Shali, MD</au><au>Than, Nandor G., MD, PhD</au><au>Soto, Eleazar, MD</au><au>Camacho, Natalia, MD</au><au>Gomez, Ricardo, MD</au><au>Quintero, Ruben, MD</au><au>Hassan, Sonia S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Twin-to-twin transfusion syndrome: an antiangiogenic state?</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>198</volume><issue>4</issue><spage>382.e1</spage><epage>382.e8</epage><pages>382.e1-382.e8</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Objective An imbalanced chronic blood flow between the donor and recipient twin through placental vascular anastomoses is the accepted pathophysiology of twin-to-twin transfusion syndrome (TTTS). Vascular endothelial growth factor receptor-1 (VEGFR-1) mRNA is overexpressed only in the syncytiotrophoblast of the donor twin in some cases of TTTS. This study was conducted to determine maternal plasma concentrations of placental growth factor (PlGF), soluble VEGFR-1, and soluble endoglin (s-Eng) in monochorionic-diamniotic pregnancies with and without TTTS. Study Design This case-control study included monochorionic-diamniotic pregnancies between 16-26 weeks with and without TTTS. Maternal plasma concentrations of PlGF, sVEGFR-1, and s-Eng were determined with ELISA. A P value &lt; .05 was considered statistically significant. Results Patients with TTTS had higher median plasma concentrations of s-Eng (14.8 ng/mL vs 7.8 ng/mL; P &lt; .001) and sVEGFR-1 (6383.1 pg/mL vs 3220.1 pg/mL; P &lt; .001]; and lower median plasma concentrations of PlGF (115.5 pg/mL vs 359.3 pg/mL; P = .002) than those without TTTS. Conclusion We propose that an antiangiogenic state may be present in some cases of TTTS.</abstract><cop>Philadelphia, PA</cop><pub>Mosby, Inc</pub><pmid>18395032</pmid><doi>10.1016/j.ajog.2008.02.016</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2008-04, Vol.198 (4), p.382.e1-382.e8
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_70482221
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
angiogenesis
angiogenic factors
Antigens, CD - blood
Biological and medical sciences
birthweight discordancy
Case-Control Studies
Endoglin
Enzyme-Linked Immunosorbent Assay
Female
Fetofetal Transfusion - blood
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
monochorionic
Neovascularization, Physiologic
Obstetrics and Gynecology
Placenta Growth Factor
placental growth factor
PlGF
Pregnancy
Pregnancy Proteins - blood
Receptors, Cell Surface - blood
sFlt1
sVEGFR-1
TTTS
twin pregnancy
Vascular Endothelial Growth Factor Receptor-1 - blood
title Twin-to-twin transfusion syndrome: an antiangiogenic state?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A46%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Twin-to-twin%20transfusion%20syndrome:%20an%20antiangiogenic%20state?&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Kusanovic,%20Juan%20Pedro,%20MD&rft.date=2008-04-01&rft.volume=198&rft.issue=4&rft.spage=382.e1&rft.epage=382.e8&rft.pages=382.e1-382.e8&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1016/j.ajog.2008.02.016&rft_dat=%3Cproquest_cross%3E70482221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70482221&rft_id=info:pmid/18395032&rft_els_id=S000293780800152X&rfr_iscdi=true